HTS US: 3012.XX.XXXX
Description
HTS Heading 3012 encompasses human blood, animal blood, and preparations thereof, which are intended for use in therapeutic, prophylactic, or diagnostic applications. This includes blood collected for transfusions, blood derivatives, and other medically relevant blood products.
Specifically, the heading covers:
- Human blood: Whole blood, plasma, and other components collected for medical use.
- Animal blood: Blood from animals prepared for similar uses as human blood.
- Blood preparations: Products obtained by processing blood, including plasma derivatives, concentrates, and other medically prepared blood products.
Code Hierarchy
- Section VI: Products of the Chemical or Allied Industries (Chapters 28-38)
- Chapter 30: Pharmaceutical Products
- Heading 3012: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes.
- US HTS Code (10-digit):
3012.XX.XXXX– The full 10-digit code specifies the exact product or preparation.
Detailed Breakdown of Subheadings
While no specific sub-codes are found in the referenced database, the international Harmonized System and USHTS further subdivide heading 3012 into products such as:
| HS/HTS Code | Description | Examples & Notes |
|---|---|---|
| 3012.10 | Human blood | Whole blood collected for transfusion or medical use. |
3012.10.0000 |
Human blood, whole | |
| 3012.20 | Animal blood prepared for therapeutic or diagnostic uses | Blood collected from animals and processed for medical applications. |
3012.20.0000 |
Prepared animal blood products | |
| 3012.30 | Antisera and other blood fractions | Includes plasma, serum, and other fractions used for immunological or therapeutic purposes. |
3012.30.0000 |
Blood fractions and antisera | |
| 3012.90 | Modified immunological products | Products obtained by biotechnological processes or other modifications, including vaccines and sera. |
3012.90.0000 |
Modified immunological blood products |
What is NOT Classified Here?
To ensure correct classification, the following are excluded from heading 3012:
- Whole blood or blood products not intended for therapeutic, prophylactic, or diagnostic use.
- Vaccines and other immunological products not based on blood or blood fractions are generally classified elsewhere within Chapter 30.
- Animal or human blood products intended for research only and not for medical use may be classified differently depending on context.
Notes
- Regulatory Oversight: Products under HTS 3012 are subject to strict regulation by agencies such as the U.S. Food and Drug Administration (FDA). Importation requires compliance with safety, quality, and labeling standards.
- Biotechnological Processes: Some products classified here may be derived or modified through biotechnology, including recombinant techniques.
- Duty Rates: Duty rates vary by specific sub-classification and product use. Importers should consult the current USHTS and applicable trade agreements for precise tariff information.
- Unit of Quantity: Typically measured in kilograms (kg) or liters (L) depending on product form.
Declaration Example
Product: Imported human plasma for therapeutic use.US HTS Code:
3012.30.0000(Blood fractions and antisera)Unit of Quantity: Liter (L)
General Duty Rate: Check current USHTS (Often duty-free or low duty under agreements)
Additional Requirements: FDA approval and import permits; compliance with health and safety regulations.
Related HTS Codes
- HTS 3002: Human blood; animal blood prepared for therapeutic uses but not included in 3012.
- HTS 3003: Medicaments consisting of two or more constituents mixed together.
- HTS 3004: Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses.
- HTS 3006: Pharmaceutical goods specified elsewhere, including vaccines not based on blood.
